Blood Advances Publishes Cellworks Prospective Genomic Biosimulation Study that Predicts Cancer Therapy Response with 90% Accuracy
Study Uses NGS Data with Biosimulation to Predict Drug Response in AML and MDS Patients
…
Cellworks myCare™ Clinical Trial Transforms NGS Data into Personalized Cancer Therapy Actions
New Trial Biosimulates Efficacy of Cancer Therapies Using Molecular Genetic Aberration Data…
Cellworks Study Predicted Non-Response to Azacitidine in MDS Patients with 100% Accuracy using AI-Driven Biosimulation
Analysis Uncovered Possible Mechanisms for AZA Resistance that could be Targeted to Induce…
Cellworks AI-Driven Biosimulation Predicted Chemo-resistance in AML and MDS Patients with 90% Accuracy
Prospective Study Successfully Identified Mechanisms for AML…